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Abstract
Background: Medial humeral epicondyle fractures of the elbow are one of the most common injuries in childhood
and often require surgery. There are currently no standardised outcome measures to assess progress after an elbow
injury in a child. Wide variation in currently reported outcomes makes comparison of treatment difficult. This study
aims to identify outcome measures that have previously been reported in studies evaluating the management of
medial epicondyle fractures in children and to facilitate the development of a consensus core outcome set (COS)
suitable for use in all future studies of medial humeral epicondyle fractures in children.
Methods/design: This study will include a systematic review of the academic literature to identify a list of outcome
measures that have previously been reported. The list of outcome measures will be used in a consensus setting
exercise with focus groups of key stakeholders to identify key outcomes. A Delphi process to include two rounds
will then be used to define the most important outcomes to all stakeholders forming the COS.
Discussion: Core outcomes represent the minimum expected data reported for a specific condition and will
improve the quality of future studies reducing bias, allowing easier comparison and enhancing opportunities
for larger meta-analysis. It is anticipated that this COS will form part of the feasibility to a National Institute
for Health Research (NIHR) Health Technology Assessment (HTA)-funded trial concerning the management of
elbow fractures in children.
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Background
Medial humeral epicondyle fractures are one of the most
common injuries in childhood and often require surgery
[1, 2]. Long-term sequelae may include non-union, mal-
union, instability, nerve injury, growth arrest, deformity
and loss of function [1, 3]. There are currently no stan-
dardised outcome measures to assess progress after an
elbow injury in a child. Wide variation in currently
reported outcomes (radiographic-, surgeon- and patient-
reported) makes comparison of the treatment of elbow
fractures in children difficult.
In particular, the management of medial epicondyle
fractures in children is controversial [1]. National
Institute for Health Research (NIHR) Health Technology
Assessment (HTA) have made children’s orthopaedic
surgery a priority area and are considering a clinical trial
in the management of medial epicondyle fractures in
children [4]. A major barrier to these trials is the lack of
a clear outcome, i.e. pain, function, fracture union,
cosmesis, quality of life.
An emerging strategy to overcome these issues has been
the development of core outcome sets (COSs). COSs rep-
resent the minimum required dataset for all randomised
control trials (RCT) of a certain condition [5–14].
The use of COSs aim to reduce heterogeneity in re-
search allowing easy comparison of studies, improve ac-
curacy of data interpretation and reduce outcome
reporting bias. Standardisation of outcomes will also lead
to a reduction in omissions and increased statistical
power for meta-analysis [15].
In recent years a small number of COSs have been de-
veloped for use in adult orthopaedics; however, these are
limited to specific conditions (hip fracture [16], back
pain [17] and total joint replacement [18]). There are
currently no COSs available for use in clinical trials
across the whole of paediatric orthopaedics.
Aims and objectives
Aim
The aim of this study is to develop a COS suitable for
use in observational research, clinical trials and routine
treatment of acute medial humeral epicondyle fractures
in children.
Objectives
The specific study objectives are:
 To identify outcomes that have previously been
reported in RCT, cohort studies, case-control
studies and case series from a systematic review
of the academic literature
 To identify outcomes important to children and
parents
 To prioritise outcomes from the perspective of key
stakeholder groups using a two-round Delphi
 To conduct a consensus meeting, compare outcomes
considered important to all stakeholders and to
integrate important outcomes into a combined COS
Methods/design
Systematic review
Search methods for identification of studies
The search strategy will be applied to the Cochrane
Central Register of Controlled Trials (CENTRAL), SCO-
PUS and MEDLINE. Multiple databases will be used to
maximise the sensitivity of the search (January 2000 to
December 2015)
The advantages conferred by using CENTRAL in
addition to the other databases is that trials from other
sources of research (e.g. journals not indexed in MED-
LINE and conference proceedings) are hand-searched,
and controlled trials from these are included. This
improves the chances of identifying all relevant studies.
Eligibility of studies
Two reviewers (SD and JS) will independently screen all
titles and abstracts of papers identified in the initial
search. Titles of articles will be reviewed and included or
excluded by using Rayyan [19]. Full-text manuscripts of
any titles/abstracts that may be eligible for inclusion, or
for which there is insufficient data in the title and
abstract to make a clear decision, will be obtained.
The full-text papers will be assessed independently by
two review authors (SD and JS) and any disagreement
on the eligibility of included studies resolved through
discussion. Where resolution is not possible, a third
review author (DP) will be consulted.
The purpose of this study is to identify all outcomes
reported irrespective of study quality. In addition as
there is no synthesis of outcome data from the included
studies, a critique of the methodological quality of the
studies is not necessary.
This process will be documented as per the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidance [20].
Data extraction
The following data will be extracted from each study:
paper and author details; year and journal of publication;
study type; inclusion criteria (Table 1) and exclusion cri-
teria, duration of follow-up; sample size; injury and in-
tervention(s) under investigation, primary and secondary
outcomes, method of measurement and time points at
which outcomes were measured.
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Outcomes
The primary aim of the systematic review is to generate
a list of all outcomes and measurement instruments re-
ported historically in eligible studies.
Data analysis and presentation
A comprehensive framework of health can be beneficial
in developing a COS, favouring the content validity of
the end product. A new framework has been developed
that aims at including all key aspects of a health condi-
tion to ensure comprehensiveness of COSs.
Outcome terms will be assigned to one of the five core
domains from the Dodd-Williamson classification
(Table 2). The five core areas that should be covered by
outcome measures to ensure a full breadth of reporting
are: (1) adverse events, (2) death, (3) physiological/clin-
ical, (4) life impact and (5) resource use [21].
A sixth domain of technical consideration will be
added for technical or surgical outcomes relevant to sur-
geons not covered by the existing framework.
Within each domain we will evaluate the number of
different outcomes used and the frequency of selection
for each individual outcome measure. We will also rec-
ord the method of measurement and the time points at
which they were measured.
Identification of potential outcomes
A list of all potential outcomes will be identified from
the systematic review as described above. Outcomes will
be listed both individually and by domain to aid inter-
pretation. All outcome domains and included outcomes
will be reviewed by the Study Steering Group (SSG) to
assess suitability of domain name and grouping. The
SSG will consist of authors SD, JJK and DP.
To identify the outcomes of importance to all stake-
holder groups a Delphi approach will be used. An over-
view of the COS developmental process is shown in
Fig. 1. This will enable participants to provide anonym-
ous opinions with equal influence given to all partici-
pants. This method also avoids individual participants’
responses being influenced by the opinion of their peers.
Key stakeholder groups will consist of children, parents
(Delphi stream 1) and clinicians (Delphi stream 2).
Identification of outcomes of importance to
patients and parents
It is essential that consideration is given to the opinions
of parents and children regarding the treatment of med-
ial humeral epicondyle fractures. They should be given
the opportunity to identify the most important outcomes
and domains based own their own experiences and
beliefs.
The opinions of children are key as they represent the
group upon which the short- and long-term benefits and
adverse effects of treatment will have the largest impact.
Medial epicondyle injuries typically affect older chil-
dren and, as such, it is unlikely that our cohort will in-
clude any young children due to the nature of the injury.
A recent national audit of medial epicondyle injuries in-
dicated that 7-year-olds were the youngest children pre-
senting with this injury pattern. Children over the age of
7 years with a previous medial humeral epicondyle
Table 1 Inclusion criteria for study selection
Study design All study designs except systematic reviews, case studies (< 10 cases) and expert opinion.
Patient population Study exclusively involving children (< 18 years) at injury, with a fracture of the medial humeral epicondyle
Interventions Any non-operative or operative intervention for management of acute medial humeral epicondyle fractures
Outcomes All outcomes
Other considerations All studies must involve at least 10 cases of medial humeral epicondyle
All studies must involve humans
All studies must be in the English language
Table 2 Overview of modified Dodd-Williamson [21] classification of outcomes
Core area Core domains Example
Adverse events Adverse events Unintended consequences
Death N/A N/A
Physiological/clinical Musculoskeletal Mal-union, non-union, range of motion
Life impact Physical/social/role/emotional/cognitive functioning
Health-related quality of life (HRQL)
Delivery of care*
PROMS, activities of daily living, satisfaction
Resource use Economic/hospital/need for intervention, societal burden Length of stay, further surgery, physiotherapy
Technical considerations Technical/surgical considerations Radiographic measurements
*Delivery of care does not refer to the resource delivery, but instead includes patient satisfaction, patient preference, adherence, withdrawal, tolerability; PROMS,
patient-reported quality of life, N/A not applicable
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fracture will be identified from a UK tertiary paediatric
centre and invited to interview. A minimum of 10
children will be recruited with no upper limit.
Eligibility will be based on history of an acute medial
humeral epicondyle fracture treated non-operatively or
operatively and the ability to complete the interview in
English without the need for a translator. Eligible children
will be invited to attend a one-off interview structured by
the use of a questionnaire. The authors feel this will
improve compliance and accurate completion of the ques-
tionnaire. This will not be audio-recorded. It will consist
of a researcher reading out the questions and recording
the answers. The survey questionnaire (Delphi stream 1)
has been designed to meet the developmental needs of a
broad array of children using a traffic-light system for
grading of outcome importance (Green ‘not important’,
Amber ‘important but not critical’ and Red ‘critical
importance’. The traffic-light scoring system has been
approved by a Young Person Advisory Group (YPAG).
Children will also have the opportunity to add any
additional outcome they feel may have been missed.
There will be no formal qualitative interview or qualita-
tive analysis.
A separate sample of 20 parents will be identified from
an existing trauma database at a UK tertiary paediatric
centre. Parents will be invited to complete an online
Delphi questionnaire (Delphi stream 1). Parents will
complete all rounds of the Delphi process.
A plain English explanation for all outcome mea-
sures listed will be included in the stream-1 question-
naire for parents and children. Language will be
approved by the YPAG.
Fig. 1 Overview of the core outcome set (COS) development process
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Consultation with the HRA deemed this study a ser-
vice evaluation project with no requirement for ethical
approval (reference 60/89/81). Informed consent will be
assumed if participants agree to fill in the surveys.
Identification of outcomes of importance to
clinicians
Overview
The Delphi (stream 2) questionnaire will consist of the
same outcomes used for children and parents but add-
itional technical and surgical considerations relevant
only to clinicians will be added.
Participants
The Delphi study will be conducted with clinicians who
have a specialist interest in paediatric trauma and ortho-
paedic surgery. Three clinician stakeholder groups will
be surveyed, comprising UK surgeons, international tri-
alists and UK physiotherapists. Clinicians will only be in-
vited to participate if they are currently involved in the
clinical care of children with medial humeral epicondyle
fractures.
Clinical leads for surgeons’ groups will be identified via
the British Orthopaedic Surgery Surveillance (BOSS)
collaborative and the Infrastructure for Musculoskeletal
Paediatric Acute Care Clinical Trials (IMPACCT) inter-
national collaborative. With the exception of IMPACCT
members, participants are not required to have previous
experience in clinical research. Eligible participants will
contacted via email and asked to complete an online
Delphi questionnaire (stream 2). A minimum of 20 par-
ticipants will be sought from the UK surgeons’ group,
and 10 from the group of international trialists.
The number of clinicians at each stage of the
process will be recorded including: total number
invited to participate; participants recruited to round
1 and numbers completing subsequent rounds. Attri-
tion rates will be documented and analysed. Each
participant will be given a unique registration number
to enable tracking of attrition at each stage of the
Delphi process. Reminder emails will be sent for
those failing to complete each round.
Bespoke Delphi manager software will be used to
ensure that all information is recorded against the par-
ticipant’s unique registration number only. Participants
will not be able to access information about other partic-
ipants or other individual’s responses.
Delphi survey
Delphi round 1
In the first round the online questionnaire will also be
used to request demographic information for registra-
tion. Information collected will include; participant’s
name, stakeholder group, clinical role, place of work and
email address. Personal information will be stored in a
separate database with a unique registration number.
At each stage of the Delphi process participants will
be given 3 weeks to complete the questionnaire. A
reminder email will be sent at the end of week 2 to
encourage completion and reduce attrition rates.
Participants who do not complete round 1 will be
excluded from participation in further rounds.
Round-1 survey format
All data will be collected using an online format. Con-
tent for round 1 will include: the participant demograph-
ics as outlined above, a list of outcomes to be scored,
listed alphabetically and by domain. Participants will be
asked to score listed outcomes and will have the option
of adding any additional outcomes of importance not
currently listed.
Participants will be asked the key question, ‘What out-
comes may influence how you treat fractures of the
medial humeral epicondyle in children’?
The Grading of Recommendations, Assessment, Devel-
opment and Evaluations scale will be used to score each
outcome. Participants will be asked to grade each listed
outcome in the format 1–9, with 1–3 deemed ‘not import-
ant’; 4–6 ‘important but not critical’ and 7–9 ‘critical
importance’.
Analysis of round 1
All additional outcomes proposed by participants will be
reviewed by two assessors (SD and JS) to ensure that
they represent new outcomes not already listed. In case
of uncertainty or disagreement a third assessor will be
consulted (DP).
The number of participants who scored each individ-
ual outcome will be recorded. The distribution of scores
will also be summarised by the stakeholder group. All
outcomes will be carried forward to round 2.
Response rate in round 1
The response rate will be assessed and presented as:
total number of participants registered; number by
stakeholder group; number completing round 1; and the
percentage of registered participants vs. invited based on
information from clinical leads.
Continuation to round 2 will be determined based on
response rate of round 1. In case of low numbers (< 10)
the protocol for future Delphi rounds will be reviewed.
Where responses do not differ greatly, an SSG review
may suggest combining appropriate stakeholder groups.
Delphi round 2
Round 2 data will be presented and recorded using an
online format. Participants will be presented with data
from all stakeholder groups. Data presented will include
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the number of respondents and distribution of scores for
all listed outcomes and any additional outcomes added
after round 1. Participants will also be able to view their
individual score from round 1.
Participants will then be asked to rescore the outcome
in light of the additional information provided. New
outcomes added in round 1 will also be scored. Any
changes to scoring from round 1 will be recorded.
Analysis of round 2
The total number of participants invited to participate in
round 2 will be documented. The number of participants
who scored each individual outcome will be recorded.
The distribution of scores will also be summarised by
the stakeholder group.
For each stakeholder group, each outcome will be clas-
sified as ‘consensus in’, ‘consensus out’ or ‘no consensus’
according to the consensus criteria (defined below).
Additional rounds of Delphi may be introduced if it is
felt by the SSG that consensus had not yet been achieved.
Consensus meeting
The final phase of the study will involve a consensus set-
ting exercise by the Consensus Focus Group (CFG). The
CFG will consist of representatives from all stakeholder
groups (UK surgeon, physiotherapist, patient and par-
ent), SSG and an independent COMET representative.
Results from round 2 of the Delphi survey will be pre-
sented and discussed followed by voting to reach a final
consensus COS.
Definition of consensus
The classification of consensus (Table 3) will be used to
determine whether a consensus has been reached or not
for each individual outcome.
In order to reach a consensus that the outcome should
be included in the COS requires agreement by the vast
majority (> 70%) that the outcome in question is of ‘crit-
ical importance’ with only a minority (< 15%) deeming it
to be of ‘no clinical importance’ [22].
For an outcome to be excluded from the COS the vast
majority (> 70%) must score the outcome as of ‘no clin-
ical importance’ with the minority (< 15%) of partici-
pants scoring it as ‘critically important’.
The threshold for definition of consensus for this
study has been predefined to prevent any bias of the end
results towards beliefs of the research team.
In the event of a ‘no consensus’ outcome, the final
decision will be made by the CFG. The structured expert
CFG will enable representatives from key stakeholder
groups to discuss differences of opinion, justify their
perspectives and make an informed decision using a
Nominal Group Technique (NGT). It will be undertaken
through face-to-face meeting. Final consensus will be
reached by means of a vote of stakeholders.
Discussion
There is currently no published COS for medial hu-
meral epicondyle fracture in children. The develop-
ment of COSs in this clinical area will improve the
quality of future studies reducing bias, allowing easier
comparison and enhance opportunities for a larger
meta-analysis. It is anticipated that this COS will
form part of the feasibility to an NIHR HTA-funded
trial concerning the management of medial humeral
epicondyle fractures in children.
Acknowledgments
None.
Funding
This work was supported by an AOUK foundation grant. Views and opinions
expressed therein are those of the authors and do not necessarily reflect
those of the AO Foundation. This article presents independent research
supported by a National Institute for Health Research (NIHR) clinician
scientist fellowship (to Daniel C Perry; grant number NIHR/CS/2014/14/012).
All authors carried out this research independently of the funding bodies.
The findings and conclusions in this report are those of the authors and do
not necessarily represent the views of the UK Department of Health.
Availability of data and materials
Data sharing is not applicable to this article as no datasets were generated
or analysed during the current study.
Authors’ contributions
DP, SD, JS and JJK conceived of the study and participated in its design. DP
and SD designed the protocol for the systematic review. SD and JS will
complete the systematic review search and extraction of eligible papers.
SD and JS will extract outcomes for the outcomes list and draft the list
of outcomes for the online Delphi. SD, RAS, JJK and DP developed the
Delphi protocol. SD will complete structured interviews with children. SD
wrote the first draft the manuscript. All authors edited the manuscript
and read and approved the final version.
Table 3 Classification of consensus [22]
Consensus
classification
Description Definition
Consensus in Consensus that outcome should be included in the core
outcome set
70% or more participants scoring as 7 to 9 and < 15% participants
scoring as 1 to 3
Consensus out Consensus that outcome should not be included in the
core outcomes set
70% or more participants scoring as 1 to 3 and < 15% of participants
scoring as 7 to 9
No consensus Uncertainty about importance of outcome Anything else
Dorman et al. Trials  (2018) 19:119 Page 6 of 7
Ethics approval and consent to participate
Consultation with the HRA deemed this study a service evaluation project with
no requirement for ethical approval (reference 60/89/81). Informed consent will
be assumed if participants agree to fill in the surveys.
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Author details
1Health Education North West (Mersey Sector), Summers Rd, Liverpool L3
4BL, UK. 2Clinical Academic Paediatric Orthopaedic Fellow, Alder Hey
Children’s Hospital, Liverpool L12 2AP, UK. 3Henry Cohen Library, University
of Liverpool, Liverpool L69 3GL, UK. 4Department of Biostatistics, University of
Liverpool, Block F Waterhouse Building, 1-5 Brownlow Street, Liverpool L69
3GL, UK. 5Institute of Translational Medicine, University of Liverpool, L693BX,
Liverpool L12 2AP, UK.
Received: 28 April 2017 Accepted: 16 January 2018
References
1. Beck JJ, Bowen RE, Silvia M. What’s new in pediatric medial epicondyle
fractures? J Pediatr Orthop. 2016. doi:https://doi.org/10.1097/BPO.
0000000000000902.
2. Tarollo L, Mugnai R, Fiacchi F, Adani R, Zambianchi F, Catani F. Pediatric
medial epicondyle fractures with intra-articular elbow incarceration. J
Orthop Traumatol. 2015;16:117–23.
3. Vallila N, Sommarhem A, Paavola M, Nietosvaara Y. Pediatric distal
humeral fractures and complications of treatment in Finland: a review
of compensation claims from 1990 through 2010. J Bone Joint Surg
Am. 2015;97(6):494–9.
4. National Institute for Health Research Health Technology Assessment
Programme. NIHR HTA Commissioning Board Minutes of the 67th Meeting.
2017. https://www.nihr.ac.uk/about-us/documents/board-and-panel-
documents/hta/HTA-Minutes-September-2017.pdf. Accessed 30 Jan 2018.
5. Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, et al.
Developing core outcome sets for clinical trials: issues to consider. Trials.
2012;13:132.
6. Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine
which outcomes to measure in clinical trials: recommendations for the
future based on a systematic review of existing studies. PLoS Med. 2011;
8(1):e1000393.
7. Sinha I, Jones L, Smyth RL, Williamson PR. A systematic review of studies
that aim to determine which outcomes to measure in clinical trials in
children. PLoS Med. 2008;5(4):e96.
8. Clarke M. Standardising outcomes for clinical trials and systematic reviews.
Trials. 2007;8:39.
9. Chan AW, Altman DG. Identifying outcome reporting bias in
randomised trials on PubMed: review of publications and survey of
authors. BMJ. 2005;330:753.
10. Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L. OMERACT: an
international initiative to improve outcome measurement in rheumatology.
Trials. 2007;8:38.
11. Lux AL, Osborne JP. A proposal for case definitions and outcome measures
in studies of infantile spasms and West syndrome: consensus statement of
the West Delphi group. Epilepsia. 2004;45:1416–28.
12. Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM,
et al. Preliminary core sets of measures for disease activity and damage
assessment in juvenile systemic lupus erythematosus and juvenile
dermatomyositis. Rheumatology. 2003;42:1452–9.
13. Harman NL, Bruce IA, Callery P, Tierney S, Sharif MO, O’Brien K, et al.
MOMENT— Management of Otitis Media with Effusion in Cleft Palate:
protocol for a systematic review of the literature and identification of a core
outcome set using a Delphi survey. Trials. 2013;14:70.
14. AMI W, Smith CT, Young B, Jones TM. The CONSENSUS study: protocol for a
mixed methods study to establish which outcomes should be included in a
core outcome set for oropharyngeal cancer. Trials. 2014;15:168.
15. Core Outcome Measures in Effectiveness Trials (COMET Initiative). 2017.
http://www.comet-initiative.org/about/background. Accessed 21 Apr 2017.
16. Haywood KL, Griffin XL, Achten J, Costa ML. Developing a core outcome set
for hip fracture trials. Bone Joint J Aug. 2014;96-B(8):1016–23.
17. Chiarotto A, Deyo RA, Terwee CB, Boers MA, Buchbinder R, Corbin TP, et al.
Core outcome set for clinical trials on non-specific low back pain. Eur Spine
J. 2015;24(6):1127–42.
18. Singh JA, Dohm M, Choong PF. Consensus on draft OMERACT core
domains for clinical trials of Total Joint Replacement outcome by
orthopaedic surgeons: a report from the International Consensus on
Outcome Measures in TJR Trials (I-COMiTT) group. BMC Musculoskelet
Disord. 2017;18:1.
19. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and
mobile app for systematic reviews. Syst Rev. 2016;5:210.
20. Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
PRISMA checklist. 2009. http://www.prisma-statement.org/
PRISMAStatement/Checklist.aspx. Accessed 19 Apr 2017.
21. Dodd S. Classification of COS outcomes. 2017. http://www.comet-initiative.
org/assets/downloads/6th-meeting/Dodd%20Classification%20of%20COS%
20outcomes.pdf. Accessed 25 Apr 2017.
22. Harman NL, Bruce IA, Kirkham JJ, Tierney S, Callery P, O’Brien K, et al. The
importance of integration of stakeholder views in core outcome set
development: otitis media with effusion in children with cleft palate. PLoS
One. 2015;10(6):e0129514.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Dorman et al. Trials  (2018) 19:119 Page 7 of 7
